UCA1 and central nervous system cancer: Patients with high expression level of UCA1 in glioma tissues had significantly lower 5-year survival rate than those with low expression level of UCA1 (P<0.05, hazard ratio = 2.156, 95% confidence interval = 1.341-5.014, P<0.05; Figure 8D).